RNA Sequencing of Solid and Cystic Lesions of the Pancreas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01807325

Enrollment

Registered

2013-03-08

Start date

2012-12-31

Completion date

2019-12-31

Last updated

2020-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Cyst, Pancreas Mass

Brief summary

The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.

Interventions

PROCEDUREpancreas biopsy

patients who are already having a pancreas biopsy will be invited to enroll. After obtaining enough tissue for usual medical care, we will divert some tissue for the study.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* greater than 18 years old, * not pregnant, * referred for endoscopic ultrasound, * have a cyst or mass of the pancreas needing diagnosis.

Exclusion criteria

* pregnant, * less than age 18, * no mass or cyst found.

Design outcomes

Primary

Measure	Time frame
Gene classifier that will classify lesions as benign or malignant with 95% certainty	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026